Retro Biosciences is raising a $1bn round to fund the artificial intelligence-powered biotech’s mission to increase human lifespan by a decade, starting by getting its first drug into trials this year ...
A closer look at OpenAI CEO Sam Altman after President Trump announces a multi-billion dollar joint venture between Altman's company, Softbank and Oracle, and why it's already drawing the ire of major ...
Results that may be inaccessible to you are currently showing.